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Abstract
Background—Pulse pressure, a measure of central arterial stiffness and a predictor of
cardiovascular mortality, has known genetic components.
Methods—To localize the genetic effects of pulse pressure, we conducted a genome-wide
linkage analysis of 1,892 American Indian participants of the Strong Heart Family Study. Blood
pressure was measured three times and the average of the last two measures was used for analyses.
Pulse pressure, the difference between systolic and diastolic blood pressures, was log-transformed
and adjusted for the effects of age and sex within each study center. Variance component linkage
analyses were performed using marker allele frequencies derived from all individuals and
multipoint identity-by-descent matrices calculated in Loki.
Results—We identified a quantitative trait locus influencing pulse pressure on chromosome 7 at
37 cM (marker D7S493, LOD=3.3) and suggestive evidence of linkage on chromosome 19 at 92
cM (marker D19S888, LOD=1.8).
Conclusions—The signal on 7p15.3 overlaps positive findings for pulse pressure among Utah
population samples, suggesting that this region may harbor gene variants for blood pressure
related traits.
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Pulse pressure, the difference between systolic (SBP) and diastolic (DBP) blood pressures,
is an independent predictor of cardiovascular (CVD) morbidity and mortality in the general
population [1,2] and among American Indian individuals [3]. Elevated pulse pressure is
associated with central artery stiffness and carotid intima-media hypertrophy, a measure of
subclinical atherosclerosis [4]. Hemodynamic changes due to increased central artery
stiffening occurs with aging, and in association with hypertension, diabetes [5], smoking,
and obesity [6]. In addition, arterial stiffness is present in individuals with microalbuminuria
[7,8].
The localization of genetic effects that influence pulse pressure has been studied in several
populations but not among American Indian individuals [9–12]. Genome-wide linkage for
pulse pressure was identified on chromosomes 7q, 17q, 18q, 19p, 20q and 21q in the Family
Blood Pressure Program (FBPP) [10] and additional loci were identified on chromosomes
6p, 10q and 22q in a recent genome-wide scan meta-analysis of Caucasians and Mexican
American individuals [13]. In this study, we sought to identify quantitative trait loci (QTLs)
for pulse pressure among American Indians, a population enriched for multiple risk factors
for atherosclerosis.
METHODS
THE STRONG HEART FAMILY STUDY
The Strong Heart Family Study (SHFS), funded by the National Heart, Lung, and Blood
Institute (NHLBI), was initiated in 1998 to study the genetics of CVD among American
Indian populations [14]. The SHFS recruited family members of the original cohort of
participants of the Strong Heart Study and it has examined over 3,600 American Indians
aged 14 to 93 years from 13 tribes. Recruitment centers were located in Arizona, North and
South Dakota, and Oklahoma. All participants provided informed consent. The SHFS
protocols were approved by the Indian Health Service Institutional Review Board, by the
Institutional Review Boards of the participating Institutions, and by the Indian tribes
participating in these studies [14].
Participants were interviewed during a clinical visit. Tobacco exposure and alcohol intake
were quantified using standardized questionnaires. Blood pressure was measured using a
standard protocol across the three recruiting centers [14]. Forearm seated blood pressures
were measured three times by a trained technician using a mercury column
sphygmomanometer (WA Baum Co) and size-adjusted cuffs. The first and fifth Korotkoff
sounds were recorded. The average of the last two of the three measures was used in the
analyses. Pulse pressure was calculated using the difference between the SBP and DBP. We
also estimated the mean arterial pressure using the equation DBP+ (pulse pressure/3).
Anthropometric measures of height and weight were used to calculate body mass index
(BMI).
Hypertension was defined using the 7th Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure (JNC 7) as blood pressure levels of
140/90 mm Hg or higher, or use of antihypertensive drugs. The American Diabetes
Association (ADA) criteria of fasting plasma glucose levels ≥ 126 mg/dl, treatment with
oral agents or insulin were used to define diabetes mellitus. Categories of obesity were
defined using the National Institutes of Health (NIH) guidelines as normal (BMI < 25 kg/
m2), overweight (BMI of 25 to < 30 kg/m2) and obese (BMI ≥ 30 kg/m2) (references
available online supplemental material). Albumin and creatinine were measured in a random
urine sample using nephelometric immunochemistry and alkaline picrate methods,
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respectively [15]. Urine albumin to creatinine ratio (ACR, mg/g) was used in analyses.
Serum creatinine was measured by the picric acid method [15].
The aortic root diameter was measured at the sinuses of Valsalva with the parasternal long-
axis view using phased-array echocardiographs with M-mode, 2D, pulsed, continuous, and
color-flow Doppler capabilities as described before [16].
Genotyping—Genotype data were generated using the ABI PRISM Linkage Map Set-
MD10 which includes ~ 400 markers spaced at approximately 10 cM intervals (references
available online). Pedigree relationships have been verified using the PREST (pedigree
relationship statistical tests) package, which employs likelihood-based inference statistics
for genome-wide identity-by-descent (IBD) allele sharing. Mendelian inconsistencies and
spurious double recombinants were detected using the SimWalk2. Marker allele frequencies
were derived using maximum likelihood methods estimated from all individuals. The overall
blanking rate for both types of errors was less than 1% of the total number of genotypes for
Arizona, the Dakotas and Oklahoma. Multipoint identity-by-descent matrices (mIBD) were
computed using LOKI 2.4. Our chromosomal maps are based on the deCODE map. We used
the University of California Santa Cruz (UCSC) website (http://genome/ucsc.edu) and
Online Mendelian Inheritance in Man (OMIM)
(http://www3.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM) databases to determine the
cytogenic location of markers and to search for candidate genes.
STATISTICAL ANALYSES
We used generalized linear models to estimate the mean age-adjusted blood pressure in
categories of potential confounders (Table 1). Quantitative traits with skewed distributions
were log-transformed (pulse pressure, BMI, ACR, and SBP). We obtained residuals from
linear regression predictive models of the log of pulse pressure using a backwards
elimination strategy (alpha = 0.10) in SAS version 9.1 (Cary, NC). A minimally adjusted
model accounted for the effects of age, age2, sex and age-by-sex interaction within center
(Model 1). Additional models adjusting for smoking (ever vs. never), alcohol intake (current
vs. not), continuous log-transformed BMI, continuous log-transformed ACR, type 2 diabetes
and hypertension treatment (yes vs. no) were also performed (Model 2). In addition, we
explored models adjusting for aortic root diameter. The residuals’ kurtoses from minimal
and maximal models were 0.42 and 0.75, respectively.
Heritability was estimated using maximum likelihood variance decomposition methods [17].
Multipoint variance component genome-wide linkage analyses were then performed using
SOLAR version 2.1.4.[17]. The variance component approach tests for linkage between
marker loci and the trait by partitioning the phenotypic variance into its additive genetic and
environmental variance components and has been described in detail elsewhere [17]. We
determined the 1-LOD unit drop support interval for all suggestive linkage results with a
LOD score greater than or equal to 1.8 [18]. Family-specific LOD scores were computed
using –pedlod in SOLAR. Linkage heterogeneity (joint test of linkage and heterogeneity)
was estimated using –hlod in SOLAR and an alpha = 0.0001. We performed power
calculations for a quantitative trait assuming that the trait was influenced by a single bi-
allelic QTL and a residual additive genetic effect due to polygenes, using –power in SOLAR
(see supplement Table 1). In addition, we performed analysis of SBP, DBP and mean
arterial pressures to determine if identified QTLs for pulse pressure were also influencing
other blood pressure phenotypes.
Genotype-by-environment interaction analyses—To test for additive genotype-by-
environment interaction, the univariate variance component model was extended to include
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the genetic covariance between the two environment relative pairs [19]. The likelihood of a
model including genotype-by- environment interaction is compared to the likelihood of
restricted models in which such interactions are excluded. We tested a model in which the
genetic correlation (rhoG) between the two groups is constrained to 1.0; and a model in
which the genetic variance (σg) among groups is constrained to be equal. In addition, we
tested a model in which the environment (residual) variances (σe) among the two groups
were constrained to be equal. For genotype-by-sex interaction models, log-transformed
pulse pressure trait was adjusted for age, age2 and recruiting centers. For genotype-by-age
interaction, we used residuals of a linear model adjusting for sex and recruiting center, and a
50 year age cutpoint categorical variable. We also performed linkage analyses including the
QTL-specific interaction term when significant (described in the online supplemental
material).
RESULTS
Analyses were performed using an available subset of 1,892 of the total 3,600 individuals
that have been genotyped in 14 large pedigrees. Among 18,349 relative-pairs, 1,530 were
parent-offspring pairs, 1,381 were sibling pairs and 2,703 were avuncular pairs. Sixty-two
percent of subjects were women, and the mean age for all participants was 42 years
(standard deviation, SD, 16). Subjects were often smokers (58%), and overweight or obese
(mean BMI of 32 kg/m2) (Table 1). Hypertension (34%) and diabetes (23%) were highly
prevalent. Mean aortic root diameter was 3.3 cm (SD, 0.4). Mean serum creatinine was 0.8
(SD, 0.4) mg/dl. Microalbuminuria or macroalbuminuria were present in approximately 19%
of individuals (Table 1).
Overall, the unadjusted mean pulse pressure was 46 mm Hg (SD 14). Pulse pressure
increased after age 50, and the age-adjusted mean pulse pressure was similar among men
and women (Table 1). Mean pulse pressure was also increased in hypertensive and diabetic
subjects but not among smokers, those with current alcohol intake or obese participants. In
addition, pulse pressure was elevated in increasing levels of urine albumin excretion (Table
1). For comparison, the mean age-adjusted SBP and DBP are also displayed in Table 1. In
linear regression models, age, sex, smoking exposure, hypertension treatment, continuous
log BMI and log ACR (p<0.01 for all), but not alcohol intake (p=0.10), type 2 diabetes
(p=0.22) or aortic root diameter (p=0.31), were significant predictors of pulse pressure
variation.
The estimated residual heritability of log of pulse pressure adjusted for age, age2, sex, age-
by-sex interaction and center was 0.25 (standard error =0.04, p=1.3 × 10−12). We identified
a QTL influencing pulse pressure on chromosome 7 at 37 cM (marker D7S493, LOD score
3.3, Figure 1) and suggestive evidence of linkage on chromosome 19 at 92 cM (marker
D19S888, LOD=1.8, Figure 2) in models adjusted for age, sex and center. The 1-LOD
support interval of the signal on chromosome 7 spanned from 32 cM (near marker D7S507)
to 44 cM (marker D7S516) (Figure 1). Adjusting for continuous log BMI, alcohol exposure,
diabetes and hypertension treatment did not substantially change the magnitude of the signal
on chromosome 7 or 19 but additional adjustments for smoking exposure or log ACR
attenuated the signal in chromosome 7 (LOD= 2.4 and 2.6, respectively) (Figure 1) but not
the signal on chromosome 19 (Figure 2). Minimally and maximally adjusted models for all
chromosomes are shown in supplemental Figure 1. Finally, models adjusting for aortic root
diameter did not change our peak linkage signals on both chromosomes 7 and 19 (data not
shown).
Although multiple families contributed to the described LOD score on chromosome 7, the
highest family-specific LOD scores were found in two large pedigrees in Dakota and
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Oklahoma (LOD scores of 1.4 and 2.1, respectively)(supplemental Figure 2). The joint test
of heterogeneity and linkage was not significant (p=0.12) and posterior probabilities for
linkage were above zero for all pedigrees (supplemental Figure 2), indicating that the
linkage to pulse pressure on chromosome 7 region was present in all families.
To determine if the QTLs on chromosomes 7 and 19 were influencing other measures of
blood pressure, we also performed linkage analysis of DBP, SBP and mean blood pressures.
The LOD scores for SBP were 0.03 and 0.97 on chromosomes 7 at 37 cM and 19 at 92 cM,
respectively (previously reported in [20]). No genetic signals were detected for DBP or
mean arterial pressure on chromosomes 7 and 19 (supplemental Figures 3 and 4).
In separate analysis using sex-specific residuals, we found no sex-specific additive genetic
effects for pulse pressure (rhoG=0.50, p=0.09 for interaction by sex). However, we found a
significant genotype-by-age interation for pulse pressure in models adjusting for sex and
center, and using the age category cutpoint of 50 years (rhoG=−0.27 ± 0.12, p=1.41 × 10−9).
The signal on chromosome 7 was attenuated in linkage analysis including the age interaction
term (LOD score=1.8) and the chromosome 19 QTL was not detected.
DISCUSSION
We identified two QTLs influencing pulse pressure in American Indians: one of the QTLs
shows significant evidence of linkage on chromosome 7 and the other shows suggestive
evidence for linkage on chromosome 19. Our findings were consistent across different
models of covariates adjustment, including adjustments for the effects of age, sex, BMI,
diabetes, alcohol intake, aortic root diameter and hypertension treatment. However, the
magnitude of the linkage peak for pulse pressure on chromosome 7 was slightly attenuated
when adjusting for smoking status or albuminuria, both of which themselves are genetically
determined.
Studies in US Caucasian and African American individuals identified QTLs for pulse
pressure and other blood pressure related traits on chromosomes 7 and 19 but our study is
the first to detect genome-wide significant linkage to this region [10,11]. The pulse pressure
QTL we identified at 7p15.3 overlaps positive findings for pulse pressure among Caucasian
Utah population participants selected for early coronary artery disease (CAD), stroke or
early onset hypertension (LOD=1.8, marker D7S1808), at approximately 6 Mb away for our
linkage peak [11]. This QTL is also within 40 Mb of a QTL for pulse pressure identified
among 779 FBPP GenNet African American participants (LOD= 3.1, marker D7S3046) [10]
and among 1584 participants of the Framingham Heart Study (LOD= 2.4, located at 71 cM
of chromosome 7) [12]. Also of interest, a QTL for carotid artery intimal medial thickness
(IMT), a measure of subclinical atherosclerosis associated with increased pulse pressure,
was recently identified in a nearby region on chromosome 7 (at 7p14.3) among the
Offspring cohort of the Framingham Heart Study (LOD=1.6) [21]. In addition, a QTL for
carotid-femoral pulse wave velocity, a more direct measure of aortic stiffness, was identified
on chromosome 7 at 29 cM in the Framingham Heart Offspring Study[22]. The QTL on
chromosome 19q has also been previously described by Camp et al for pulse pressure
(marker D19S245, LOD=2.0) and more recently by the NHLBI FBPP in African American
subjects (LOD=2.3) [10,11]. Although a recent meta-analysis of pulse pressure linkage
studies did not identify chromosomes 7 or 19 as regions of interest for pulse pressure, the
study reported evidence for substantial genetic heterogeneity for this trait [13].
Approximately 86 genes underlie the 1-LOD support interval of the 7p15.3 QTL, of which
two positional candidate genes have been associated with hypertension and/or
atherosclerosis: interleukin-6 (IL-6 at 7p21) and neuropeptide Y (NPY at 7p15.1). IL-6 is an
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acute inflammatory cytokine and an inducer of C-reactive protein. High levels of IL-6 were
seen in hypertension and increased pulse pressure [23], and were also associated with the
development and the progression of atherosclerosis and CVD mortality [24]. A
polymorphism in the promoter of the IL-6 gene (-174G/C) was associated with increased
carotid artery IMT [25] and coronary artery disease [26] but has not been studied for
association with pulse pressure. Neuropeptide Y is a vasoactive neuropeptide that regulates
appetite and vascular reactivity. Polymorphisms of NPY were associated with hypertension,
increased carotid artery IMT [27], myocardial infarct and stroke [28]. In addition, NPY
variants were associated with insulin resistance [29] which is highly prevalent in American
Indians in the Strong Heart Study.
Located in the chromosome region 19q13.3-13.41 is a cluster of 15 genes of the kallikrein
family. Kallikreins are tissue-specific enzymes that generate kinins, which affect blood
pressure and renal function. Variants of the kallikrein 1 (KLK1) gene are associated with
hypertension in Han Chinese populations [30].
The identified QTL on chromosome 7 was specific to the pulse pressure phenotype but the
QTL on chromosome 19 was also localized using the SBP trait. The FBPP has also showed
some overlap between SBP and pulse pressure QTLs [10]. Interestingly, we did not see an
overlap in QTLs for pulse pressure and mean arterial pressure, the later measure being the
steady-flow component of the blood pressure curve. Minimal overlap in linkage peaks to
blood pressure components have also been previously reported [12,31].
We identified an interesting genotype-by-age interaction for pulse pressure, supporting a
genetic basis for the physiologic differences observed in pulse pressure in young compared
to older individuals. In linkage analysis accounting for age interaction, the QTL on
chromosome 7 was attenuated and the evidence for linkage on chromosome 19 disappeared.
These findings may be due to differences in the age effects within categories of risk factors
for atherosclerosis, for example, the age effects may vary with gender or hypertensive status.
In addition, reduced power to detect the effects may occur when using age categories.
Lastly, the possibility that the chromosome 19 QTL is a false positive must also be
considered. Further studies are needed to clarify the relationship between genotype, age, and
pulse pressure.
Our study used averages of two blood pressure measures for estimation of pulse pressure
which decrease the variability of the blood pressure trait. Misclassification of hypertension
status could have occurred for individuals classified based on the single day average
measure of blood pressure (36% of hypertensive individuals were classified using only
blood pressure measures). Although two large families accounted for most of the linkage
signal on chromosome 7, the joint test of heterogeneity and linkage was not significant,
indicating that all families contributed to the linkage signal.
In summary, we found genome-wide evidence for linkage to pulse pressure on chromosome
7p and suggestive evidence for linkage on 19q among American Indian participants of the
Strong Heart Family Study. Our study provides corroboration of genomic regions that
possibly influence interindividual variation in pulse pressure on chromosomes 7p and 19q.
In addition, the 7p region encompasses candidate genes known to affect blood pressure and
hypertension, as well as markers of subclinical atherosclerosis. The identification and
confirmation of QTLs for pulse pressure will bring us closer to the identification of the
functional genes that influence pulse pressure and aid in disentangling the complex etiology
of cardiovascular disease.
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Chromosome 7 multipoint LOD scores for log-transformed pulse pressure. Model 1: log
pulse pressure adjusted for age, age2, sex, age-by-sex interaction, center; Model 2: log pulse
pressure adjusted for age, age2, sex, age-by-sex interaction, center, diabetes, smoking, log
urine albumin excretion, log body mass index, hypertension treatment; Model 3: Model 2
without adjusting for log urine albumin excretion (smoking effect); Model 4: Model 2
without adjusting for smoking (urine albumin excretion effect).
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Chromosome 19 multipoint LOD scores for log-transformed pulse pressure. Model 1: log
pulse pressure adjusted for age, age2, sex, age-by-sex interaction, center; Model 2: log pulse
pressure adjusted for age, age2, sex, age-by-sex interaction, center, type 2 diabetes, smoking,
log urine albumin excretion, log body mass index, hypertension treatment; Model 3: Model
2 without adjusting for log urine albumin excretion (smoking effect); Model 4: Model 2
without adjusting for smoking (urine albumin excretion effect).
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TABLE 1
Characteristics of the American Indian participants: The Strong Heart Family Study (n=1,892)
Mean pulse pressure mm Hg (95% CI)
Mean systolic/diastolic blood pressures,
mm Hg
Age < 50 years (n=1340) 42 (41, 43) 119/77
Age 50 or older (n=552) 56 (55, 57) 131/75
Female (n=1169) 46 (45, 46) 120/75
Male (n=723) 47 (46, 48) 126/80
Normotensive subjects (n=1250) 43 (43, 44) 117/74
Hypertensive participants not on treatment (n=229) 52 (50, 54) 142/90
Hypertensive participants on treatment (n=413) 51 (50, 53) 129/78
Non-diabetic participants (n=1443) 46 (45, 46) 122/77
Diabetic participants (n=449) 48 (46, 49) 124/76
Never smokers (n=789) 46 (45, 47) 122/76
Ever smokers (n=1103) 46 (45, 47) 123/77
No alcohol intake (n=791) 47 (46, 48) 121/74
Current alcohol intake (n=1101) 46 (45, 46) 124/78
BMI lower than 25, kg/m2 (n=286) 46 (45, 48) 117/71
BMI 25 to less than 30, kg/m2 (n=481) 45 (44, 47) 122/77
BMI 30 or more, kg/m2 (n=1125) 46 (46, 47) 124/78
Urine albumin <30 mg/g creatinine (n=1530) 45 (45, 46) 122/76
Urine albumin 30 to 300 mg/g creatinine (n=283)* 48 (47, 50) 125/77
Urine albumin >300 mg/g creatinine (n=79)** 57 (54, 60) 136/79
CI, confidence interval; BMI, body mass index
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